Darktrace IPO: Everything you need to know about Darktrace
Ben Lobel April 30, 2021 6:05 PM
Darktrace emerged as a luminary of artificial intelligence-led cybersecurity in 2013 and progressed to unicorn status by 2018. Find out what you need to know about the company following its IPO in April 2021.
When is the Darktrace IPO?
Darktrace made its market debut on the London Stock Exchange on April 30 at 250p a share. The transaction gave the company a valuation of £1.7 billion.
Shortly after 8am GMT, the company's shares rose to more than 358p, representing a 43% boost from its original IPO price.
While Darktrace had lowered its pricing for the float from a rumoured £3 billion valuation, the company is expected by some analysts to successfully ride the wave of anticipation surrounding fast-growth tech stocks. The London listing will be closely watched following the disappointing Deliveroo IPO in March.
Read about more IPOs set for 2021.
How much is Darktrace worth?
Darktrace is worth £1.7 billion based on its IPO on April 30 2021.
As of 2018 Darktrace was valued at $1.65 billion following a $50 million Series E funding round. The company’s Series D round amounted to $75 million in 2017, which valued the company at $825 million. Before that, Darktrace also raised $64 million in 2016, and $23 million in 2015.
How to trade Darktrace shares
Darktrace shares are available to trade with City Index following its April IPO.
You can start trading shares in just a few quick steps:
- Open a City Index account, or log in if you’re already a customer
- Search for Darktrace in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
What is Darktrace?
Darktrace is an artificial intelligence (AI) company with a focus on cybersecurity. It develops solutions for organisations to detect emerging online threats, using technology based on machine learning and AI algorithms to prepare clients for potential attacks.
The company works by installing an appliance in a client’s network infrastructure. The device employs its machine learning capabilities to detect suspicious activity, using Bayesian mathematical equations to assess the probability of an attack, and neutralises threats before they turn into crises.
Darktrace’s products include Darktrace Industrial, Darktrace Enterprise, Darktrace Cloud and Darktrace SaaS, all software applications designed to target threats from various online sources.
Headquartered in Cambridge, the company has more than 1,500 employees across 44 offices globally, and saw revenues of more than £100 million for its latest accounts filed in 2019.
How does Darktrace make money?
Darktrace makes money through cybersecurity contracts with corporations, governments and banks, reportedly charging clients based on the number of IP addresses or networked devices managed.
This can result in a contract being worth anything from a few thousand to several hundred thousand pounds per month.
The company has counted Micron, Rolls-Royce, Coca-Cola, Siemens, and NHS trusts as some of its key customers.
Is Darktrace profitable?
As of its latest 2019 accounts, Darktrace is not a profitable business, having racked up losses of £21.8 million on revenues of some £100 million. However, these losses were trimmed from £27.6 million the prior year.
Founder Poppy Gustafsson said in 2018 that the profitability of the business was being put on hold as the company’s high-growth phase placed hiring and international expansion as an immediate priority.
Who are Darktrace’s competitors?
Darktrace’s competitors include IT multinationals such as Cisco, which offers its own b2b cyber defence solutions, as well as specialist cybersecurity companies such as Fortinet, Palo Alto Networks, FireEye and ESET. Additionally, there are a host of other companies releasing new products in response to the constantly-evolving cybersecurity marketplace.
While Darktrace’s revenues are currently dwarfed by many of the American cybersecurity giants in a hugely competitive sector, the company is widely considered to be a major early adopter and leading innovator specifically of AI-based cybersecurity solutions. Today, however, as more and more companies enter the AI space, Darktrace may find tougher barriers to scale than previously encountered.
What is Darktrace’s strategy?
From its launch in 2013, Darktrace set out to ‘fundamentally transform the ability of organisations to defend their most critical assets in the face of rising cyber threat’. On launch, the company’s technology was widely regarded as pioneering in its design to enable network infrastructures to mirror the human immune system in dealing with threats.
The strategy evolved over the years to incorporate Autonomous Response technology, which allowed the ‘immune system’ to react to in-progress cyberattacks with a higher degree of precision. 2019 saw the release of the Cyber AI Analyst, which further strengthened a company’s ability to defend attacks through automation of the threat investigation and reporting process.
Who are the directors of Darktrace?
Darktrace was founded in 2013 by Poppy Gustafsson, Jack Stockdale, Dave Palmer, Emily Orton, and Nicole Eagan. In addition to the core founders, there are a number of prominent board members and advisors, including Robert Webb QC, former General Counsel of Rolls Royce and British Airways, and Alan Wade, former CIO of the CIA.
Here are some of the key personnel at the company:
- CEO and Director: Poppy Gustafsson
- Chief Financial Officer: Cathy Graham
- Chief Technology Officer: Jack Stockdale
- Chief Technology Officer, Americas: Eloy Avila
- Chief Marketing Officer: Emily Orton
- Chief Information Security Officer: JR Tietsort
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.